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Abstract: 
The key problem for the treatment of drug addiction is relapse to drug use 
after abstinence that can be triggered by drug-associated cues, re-
exposure to the drug itself and stress. Understanding the neurobiological 
mechanisms underlying relapse is essential in order to develop effective 
pharmacotherapies for its prevention. Given the evidence implicating the 
metabotropic glutamate receptor 5 (mGlu5R), µ-opioid receptor (MOPr), κ-
opioid receptor (ΚOPr) and oxytocin receptor (OTR) systems in cocaine 
addiction and relapse, our aim was to assess the modulation of these 
receptors using a mouse model of cue- and priming-induced reinstatement 
of cocaine-seeking.  Male mice were trained to self-administer cocaine (1 
mg/kg/infusion, i.v.) and were randomised into different groups: i) cocaine 
self-administration ii) cocaine extinction, iii) cocaine-primed (10mg/kg i.p.) 
or iv) cue-induced reinstatement of cocaine-seeking. Mice undergoing the 
same protocols but receiving saline instead of cocaine were used as 
controls. Quantitative autoradiography of mGlu5R, MOPr, KOPr and OTR 
showed a persistent cocaine-induced upregulation of the mGlu5R and OTR 
in the lateral septum and central amygdala respectively. Moreover a 
downregulation of mGlu5R and MOPr was observed in the basolateral 
amygdala and striatum respectively.  Further, we showed that priming- but 
not cue-induced reinstatement upregulates mGlu5R and MOPr binding in 
the nucleus accumbens core and basolateral amygdala respectively, whilst 
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cue- but not priming-induced reinstatement downregulates MOPr binding in 
caudate putamen and nucleus accumbens core. This is the first study to 
provide direct evidence of reinstatement-induced receptor alterations that 
are likely to contribute to the neurobiological mechanisms underpinning 
relapse to cocaine-seeking. 
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Abstract: 
The key problem for the treatment of drug addiction is relapse to drug use after abstinence 
that can be triggered by drug-associated cues, re-exposure to the drug itself and stress. 
Understanding the neurobiological mechanisms underlying relapse is essential in order to 
develop effective pharmacotherapies for its prevention. Given the evidence implicating the 
metabotropic glutamate receptor 5 (mGlu5R), µ-opioid receptor (MOPr), κ-opioid receptor 
(ΚOPr) and oxytocin receptor (OTR) systems in cocaine addiction and relapse, our aim was 
to assess the modulation of these receptors using a mouse model of cue- and priming-induced 
reinstatement of cocaine-seeking.  Male mice were trained to self-administer cocaine (1 
mg/kg/infusion, i.v.) and were randomised into different groups: i) cocaine self-
administration ii) cocaine extinction, iii) cocaine-primed (10mg/kg i.p.) or iv) cue-induced 
reinstatement of cocaine-seeking. Mice undergoing the same protocols but receiving saline 
instead of cocaine were used as controls. Quantitative autoradiography of mGlu5R, MOPr, 
KOPr and OTR showed a persistent cocaine-induced upregulation of the mGlu5R and OTR in 
the lateral septum and central amygdala respectively. Moreover a downregulation of mGlu5R 
and MOPr was observed in the basolateral amygdala and striatum respectively.  Further, we 
showed that priming- but not cue-induced reinstatement upregulates mGlu5R and MOPr 
binding in the nucleus accumbens core and basolateral amygdala respectively, whilst cue- but 
not priming-induced reinstatement downregulates MOPr binding in caudate putamen and 
nucleus accumbens core. This is the first study to provide direct evidence of reinstatement-
induced receptor alterations that are likely to contribute to the neurobiological mechanisms 
underpinning relapse to cocaine-seeking. 
 
Keywords: cocaine, mGlu5, opioid, oxytocin, relapse, self-administration 
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Introduction 
Cocaine is a psychostimulant showing the highest prevalence of consumption in Europe 
(EMCDDA 2014). Cocaine addiction is a relapsing brain disorder characterised by 
compulsion to seek and take the drug, loss of control in limiting intake, and emergence of a 
negative emotional state following abstinence (Le Moal and Koob 2007). The key problem 
for the treatment of cocaine addiction is the repeated cycles of relapse to drug use after 
periods of abstinence (O'Brien 2005). In humans, relapse to cocaine administration can be 
triggered by exposure to the drug itself, by cues previously associated with drug 
administration, and/or by stress (Bossert et al. 2013). To date, there is no effective 
pharmacotherapy for the treatment of cocaine addiction and prevention of relapse (see Yoo et 
al. 2012). Therefore, the delineation of the neuronal mechanisms underpinning relapse to 
cocaine use is critical in order to develop targeted pharmacotherapy for its prevention. 
 
While several neurotransmitter systems have been implicated in the regulation of 
reinstatement of cocaine-seeking behaviour (Bossert et al. 2013), differences between the 
neurobiological circuitries involved in the different types of reinstatement also exist (Bossert 
et al. 2013). However, the precise neurochemical mechanisms underlying the priming, cue- 
and stress induced relapse to cocaine-seeking following abstinence remain to be elucidated. 
 
There is evidence demonstrating a role for the metabotropic glutamate receptor type 5 
(mGlu5R) in the mediation of cocaine reinstatement (Kalivas 2009). In particular, systemic 
(Backstrom and Hyytia 2006; Kumaresan et al. 2009; Martin-Fardon et al. 2009) and 
intra-accumbal administration of mGlu5R negative allosteric modulators in both the core 
(AcbC) (Wang et al. 2013) and shell (AcbSh) sub-compartment, attenuated cocaine-
induced reinstatement in rodents. Moreover, cue-induced reinstatement of cocaine-
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seeking was also attenuated by systemic (Backstrom and Hyytia 2006; Kumaresan et al. 
2009; Martin-Fardon et al. 2009) and intra-AcbC (Wang et al. 2013) administration of 
mGlu5R negative allosteric modulators. 
  
The endogenous opioid system and specifically the MOPr and KOPr systems have also 
been implicated in the reinstatement of cocaine-seeking behaviour. While intra-Acb 
injection of selective MOPr agonists triggered reinstatement of cocaine-seeking 
(Simmons and Self 2009), intra-Acb injection of MOPr antagonists reduced cocaine self-
administration (Ward et al. 2006) and cocaine-primed reinstatement (Simmons and Self 
2009; Tang et al. 2005) of cocaine-seeking in rodents. Interestingly, an increase in MOPr 
occupancy was detected in the frontal and temporal cortices of former cocaine addicts, 
which was positively correlated to relapse potential (Gorelick et al. 2008), further 
demonstrating the key involvement of MOPr in relapse behaviour. The endogenous 
KOPr system has been implicated in the reinstatement of cocaine-seeking behaviour 
since activation of this system reinstates cocaine-seeking both in mice and monkeys 
(Redila and Chavkin 2008; Valdez et al. 2007). Moreover, systemic or intra-ventral 
tegmental area (VTA) administration of ΚOPr antago ists decreased stress-induced 
reinstatement of cocaine CPP in rodents (Graziane et al. 2013; Redila and Chavkin 2008) 
and oral administration of a selective ΚOPr antagonist prevent cocaine-primed 
reinstatement in mice (Aldrich et al. 2013).  
 
Recent evidence suggests a key role for the neurohypophysial peptide oxytocin (OT) in the 
modulation of reinstatement to psychostimulant drugs of abuse (Broadbear et al. 2011; 
McGregor and Bowen 2012; Sarnyai 2011).  Specifically, systemic administration of OT has 
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been shown to attenuate priming- (Carson et al. 2010) and stress- (Qi et al. 2009) induced 
reinstatement of methamphetamine-seeking behaviour in rodents.  
As mGlu5R, MOPr, ΚOPr and OTR have been implicated in psychostimulant reinstatement 
behaviours, we hypothesised that cue- and priming-induced reinstatement of cocaine-
seeking might induce region-specific alterations in these receptors in the brain. To test this 
hypothesis, we assessed the density of mGlu5R, MOPr, ΚOPr and OTR using 
autoradiographic mapping in brains of mice subjected to an operant cocaine self-
administration paradigm, extinction and cue- and priming-induced reinstatement of 
cocaine-seeking. This study provides novel information about the neurobiological 
substrates involved in cocaine reinstatement behaviour. 
Materials and Methods 
Animals 
Male CD-1 outbred mice (Charles River, France), weighing 20–25 g upon arrival at the 
laboratory, were individually housed under a 12-h light-dark cycle (lights on at 8:00am), at 
constant temperature (21 ± 1°C) and humidity (55 ± 10%). Food and water were provided ad 
libitum. Mice were handled daily by the experimenter for one week prior the start of the 
experiment to minimise handling stress. Animal care and experimental procedures were in 
accordance with institutional and international standards (the European Communities Council 
Directive 86/609/EEC, 24 November 1986) and approved by the local Ethics Committee 
(CEEA-PRBB). 
Operant cocaine self-administration 
The cocaine self-administration and reinstatement procedures were performed as previously 
described (Soria et al. 2008). Briefly, mice were implanted with intravenous silastic catheters 
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and, after a recovery period of three days, they were trained to self-administer cocaine 
hydrochloride, 1 mg/kg/infusion (Ministerio de Sanidad y Consumo, Spain), at the fixed ratio 
1 of reinforcement. The training consisted of 2-h daily self-administration sessions and was 
conducted in operant chambers (MED Associates, Georgia, VT, USA) equipped with nose-
poke holes. When the animal poked the ‘active’ hole a cocaine infusion was obtained 
simultaneously with a light cue. Poking of the ‘inactive’ hole had no effect. The training was 
carried out during 12 consecutive days. Following the 12-day acquisition period, those that 
achieved the acquisition criteria of self-administration as described by Soria et al. (2008) 
were subjected to an extinction period which consisted of two 2-h daily sessions in the 
operant cages, during which nose poking was not reinforced by cocaine administration. The 
extinction training was carried out for 6 days per week until the mice reached the extinction 
criteria as described in Soria et al. (2008).  
Following the extinction period, animals were tested for priming- and cue-induced 
reinstatement of nose-poke behaviour elicited either by a priming injection of cocaine (10 
mg/kg, i.p.) given immediately prior to the placement of mice in the operant chamber or by 
presentation of the conditioned light cue previously associated with cocaine administration. 
During the 2-hour reinstatement sessions, nose-pokes in the ‘active’ hole did not result in 
infusion of cocaine at any time point. An animal was considered to be a responder in the 
reinstatement test when the number of nose pokes on the ‘active’ hole was at least double the 
corresponding nose-pokes during the last extinction session and when the number of 
responses on the ‘active’ hole was equal or greater than ten. Mice undergoing the same 
protocols but receiving saline infusion instead of cocaine were used as controls for self-
administration, cue- and priming-induced reinstatement. The drop-out rate of mice not 
reaching acquisition criteria and not reinstating are summarised in table S1. 
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Autoradiography 
All the animals from the aforementioned experiments were euthanized by decapitation 24 
hours after the last 2h-session in the operant chamber. Coronal brain sections were cut (20 
µm thick; 300 µm apart) using a cryostat (Zeiss Microm 505E, Hertfordshire, U.K.), thaw-
mounted onto gelatin subbed ice-cold microscope slides and processed for autoradiography, 
as described previously (Kitchen et al. 1997).  
For mGlu5R quantitative autoradiography, slides were pre-incubated in 50 mM Tris-HCl 
buffer, containing 120mM NaCl, 5mM KCl, 2mM CaCl2 and 1mM MgCl2 (pH 7.4, room 
temperature; 20 min) in order to remove endogenous glutamate. To determine total binding, 
slides were incubated for 60 minutes in 10 nM [
3
H]-2-methyl-6-([3,5-3H] phenylethynl) 
pyridine (MPEP) (American Radiolabeled Chemical, 2.22 TBq/mmol) in Tris-HCl buffer (pH 
7.4, 4
◦
C).  For the determination of non-specific binding (NSB) adjacent sections were 
incubated in [
3
H]MPEP (10 nM) in the presence of 10µM fenobam (Tocris Bioscience, 
Bristol, UK). Receptor binding was terminated by two rapid rinses in ice-cold Tris-HCl 
buffer (2 x 1 min, ph 7.4) and a final rinse in ice-cold distilled water before being rapidly 
dried in cool air for 2 hours.  
MOPr autoradiography was carried out as previously described (Bailey et al. 2005; Bailey et 
al. 2007a; Bailey et al. 2007b). For the determination of total binding, slides were incubated 
for 60 minutes in 4 nM [
3
H]-tyrosyl-3,5-3H(N) (DAMGO) (PerkinElmer, 1905.5 GBq/mmol) 
in Tris-HCl (pH 7.4, room temperature).  Adjacent sections were incubated in [
3
H]DAMGO 
(4nM) in the presence of 1 µM naloxone (Sigma-Aldrich, Poole, UK), to determine NSB.  
 
ΚOPr quantitative autoradiography was carried out as previously described (Nock et al. 
1988) with minor modifications. For the determination of total binding, slides were incubated 
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in 5nM [
3
H]-phenyl-3, 4-3H (U69-593) (PerkinElmer, 1613 GBq/mmol) in 50mM Tris-HCl 
buffer (pH 7.4, room temperature), for 90 minutes.  Adjacent sections were incubated with 
[
3
H]U69-593 (5nM) in the presence of 10 µM naloxone, to determine NSB.  
 
OTR autoradiography was carried out as previously described (Zanos et al. 2014a; Zanos et 
al. 2014b). For the determination of total binding, slides were incubated in 50 pM [
125
I]-
ornithine vasotocin (OVTA) (PerkinElmer, 81.4 TBq/mmol) in an incubation buffer medium 
(50 mM Tris–HCl, 10 mM MgCl2, 1 mM EDTA, 0.1% w/v bovine serum albumin, 0.05% 
w/v bacitracin; Sigma-Aldrich, Poole, UK, pH 7.4 at room temperature) for  60 minutes. For 
the determination of NSB, adjacent sections were incubated with [
125
I]-OVTA (50 pM) in the 
presence of 50 µM unlabelled (Thr4, Gly7)-oxytocin (Bachem, Germany).   
 
Different apposition times were used depending on the autoradiographic binding (mGlu5R 
binding - 3 weeks; MOPr binding - 10 weeks; ΚOPr binding - 8 months; OTR binding - 3 
days). Slides with brains sections from all the treatment groups were laid down against the 
same film (Kodak BioMax MR-1 ﬁlms; Sigma-Aldrich, Gillingham, UK) along with 
appropriate 
3
H and 
14
C microscale standards (Amersham Pharmacia Biotech, Bucks, U.K.)  to 
allow quantiﬁcation, developed and analysed in parallel in a complete paired protocol as 
described by Kitchen et al. (1997). All structures were identiﬁed by reference to the mouse 
brain atlas of Franklin & Paxinos (2001), and analysed using an image analyzer (MCID; 
Image Research, Linton, UK). 
Statistical analysis: 
 
All the values were expressed as mean ± SEM. For analysis of acquisition of cocaine self-
administration behaviour repeated measures two-way ANOVA with factors ‘hole’ (i.e., active 
and inactive) and ‘time (day)’ was performed. For the analysis of priming- and cue- induced 
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reinstatement of cocaine-seeking behaviour, two-way ANOVA was performed with factors 
‘hole’ (i.e., active and inactive) and ‘experimental phase’ (ie, last day of self-administration, 
first day of extinction, last day of extinction and priming- or cue-induced reinstatement). For 
analysis of treatment and experimental phase on mGlu5R, MOPr, ΚOPr and OTR 
autoradiographic binding, two-way ANOVA with factors ‘treatment’ (i.e., saline and cocaine) 
and ‘experimental phase’ (i.e., self-administration, priming- and cue-induced reinstatement) 
were performed in each brain region analysed. The effect of ‘experimental phase’ (i.e., self-
administration, extinction, priming- and cue-induced reinstatement) on the cocaine-treated 
groups on receptor autoradiographic binding was analysed by one-way ANOVA in each brain 
region. ANOVAs were followed by a Holm-Sidak post hoc test when significant interaction 
effect was reached (i.e., p<0.05). All relevant F-values are provided in Table S2. All 
statistical analyses were performed using SigmaPlot (Systat Software, London, UK). 
 
Results 
 
Acquisition, extinction, priming- and cue- induced reinstatement of cocaine self-
administration behaviour 
The results for acquisition of self-administration were pooled from all experimental groups 
which involved acquisition of self-administration. During the 12-day training period, mice 
readily learned to discriminate between the active and inactive hole. A significant ‘time’ x 
‘hole’ interaction indicated that animals increased the number of responses on the active hole 
with time. The response to the active hole compared to the inactive hole reached statistical 
significance on day 4 and persisted until the last day of the training period (Fig 1A). 
The mice that reached the acquisition and extinction criteria were then separated into two 
groups, the cue- and priming-induced reinstatement groups. In both groups a significant 
‘experimental phase’ effect, as well as a significant ‘experimental phase’ x ‘hole’ interaction 
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was observed, indicating that mice responded differentially to the active and inactive holes in 
each phase. Holm-Sidak post-hoc test revealed that cocaine self-administration induced an 
increase in the number of responses on the active hole compared to the inactive hole. This 
increase persisted during the first day of the extinction period in both groups (Fig. 1B,C) but 
responses to the two holes were not significantly different on the last day of the extinction 
period demonstrating that cocaine-seeking behaviour was successfully extinguished. During 
the reinstatement testing both presentation of the cocaine-associated cue and a priming 
injection (10 mg/kg, i.p.) were able to induce reinstatement of cocaine-seeking behaviour 
since responses to the active hole were significantly higher compared to the inactive hole 
(Fig. 1B,C).  Moreover, the responses of the animals to the active hole were increased in both 
cue- and priming- reinstatement phases compared to the last day of the extinction phase (Fig. 
1B,C). The priming injection of cocaine was a stronger stimulus in inducing reinstatement 
compared to the presentation of the light cue as shown by the higher responses to the active 
hole (47.11±2.77 vs 27.31±3.77 nose pokes; p<0.01, Fig 1B,C). 
Effect of cocaine self-administration, extinction, priming- and cue- induced 
reinstatement of cocaine-seeking on mGlu5R, MOPr, ΚOPr and OTR binding in mouse 
brain 
 
mGlu5R autoradiography 
Quantitative analysis of mGlu5R binding showed a significant treatment effect in the 
basolateral amygdala (BLA) and lateral septum (LS) (Fig. 2B, Table S2). Higher overall 
levels of mGlu5R binding were detected in the LS of the groups of mice subjected to cocaine 
self-administration and reinstatement compared to saline controls (Fig. 2A,B).  On the other 
hand, lower overall levels of mGlu5R binding were observed in the BLA of animals trained to 
self-administer cocaine compared to the saline controls (Fig. 2A,B).  A significant effect for 
the factor ‘experimental phase’ but not of ‘treatment’ was observed in the nucleus accumbens 
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core (AcbC).  Analysis of cocaine self-administration and reinstatement of cocaine-seeking, 
to test the effect of experimental phase (i.e., self-administration, extinction, priming- and cue-
induced reinstatement) revealed a significant upregulation of mGlu5R binding in priming-
induced reinstatement of cocaine-seeking compared to cocaine self-administration, extinction 
and cue-induced reinstatement of cocaine-seeking in the AcbC (Fig. 2C). No differences were 
shown in any other brain region analysed (Fig. 2B,C; Table S3). Moreover, one-way 
ANOVA within the saline groups in each individual brain region did not reveal any 
significant differences between the experimental phases. No significant ‘treatment’, 
‘experimental phase’ or interaction between these two factors was observed in any other 
brain regions analysed (Fig. 2B, Table S3). 
MOPr autoradiography 
Quantitative analysis of MOPr binding showed a significant ‘treatment’ and ‘experimental 
phase’ effect in the nucleus accumbens shell (AcbSh), AcbC and caudate putamen (CPu) (Fig 
3B, Table S2). Decreased MOPr binding was observed in the AcbSh in mice subjected to 
cocaine self -administration compared to saline controls, irrespective of the experimental 
phase (Fig. 3A,B).   Moreover, in the AcbC and CPu a significant ‘treatment’ x ‘experimental 
phase’ interaction was identified. Holm-sidak post-hoc test revealed a significant decrease in 
MOPr binding in the AcbC and CPu in mice subjected to cocaine self-administration and cue-
induced reinstatement of cocaine-seeking compared to their respective saline controls (Fig. 
3B).  This downregulation was not observed in the priming-induced reinstatement group.  No 
significant differences in ‘treatment’ or ‘experimental phase’ were observed in any of the 
other brain regions analysed (Fig. 3B, Table S4). Analysis of the effect of ‘experimental 
phase’ (i.e., self-administration, extinction, priming- and cue-induced reinstatement) within 
the cocaine groups on MOPr autoradiographic binding (Fig. 3C) revealed a significant effect 
in the AcbC, CPu, VDB and BLA. Higher levels of MOPr binding were observed in cocaine-
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primed reinstatement in the AcbC (vs cue-reinstatement), CPu (vs self-administration and 
cue- reinstatement) and VDB (vs self-administration) (Fig 3C). In the BLA, lower levels of 
MOPr binding were observed in mice subjected to extinction from cocaine self-
administration compared to the cocaine self-administration group (Fig 3C). However, 
priming- but not cue-induced reinstatement of cocaine-seeking restored MOPr binding to the 
levels of cocaine-self administration (vs cocaine extinction) (Fig 3C).  No significant 
treatment or experimental phase differences were observed in any other brain region analysed 
(Fig. 3B,C; Table S2; Table S4). Moreover, one-way ANOVA within the saline groups in 
each individual brain region did not reveal any significant differences between the 
experimental phases. 
ΚOPr autoradiography 
Quantitative analysis of ΚOPr binding showed no significant ‘treatment’ or ‘experimental 
phase’ effects in any of the regions analysed (Table 1; Table S2). One-way ANOVA of ΚOPr 
binding in brains of mice undergoing cocaine self-administration, extinction, priming- and 
cue-induced reinstatement showed a significant experimental phase effect in the BLA. 
However, Holm-Sidak post-hoc test did not show any significant differences between the 
experimental phases. No significant ‘experimental phase’ effect was observed in any other 
brain region analysed. No significant ‘experimental phase’ effect was detected between the 
saline treated groups in any of the regions analysed (Table 1; Table S2).  
OTR autoradiography 
Quantitative analysis of OTR binding showed a significant ‘treatment’ effect in the central 
nucleus of amygdala (CeA) (Table 2; Table S2). Higher levels of OTR binding were detected 
in the CeA of cocaine treated groups compared to saline controls. No significant differences 
were found in the other brain regions analysed. One-way ANOVA of OTR binding in brains 
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of mice undergoing cocaine self-administration, extinction, priming- and cue-induced 
reinstatement showed no significant experimental phase effect in any of the regions analysed. 
No significant experimental phase effect was detected between the saline treated groups in 
any of the regions analysed (Table 2; Table S2). 
Discussion 
 
This study demonstrates brain-specific alterations of mGlu5R, MOPr and OTR binding 
induced by cocaine self-administration and reinstatement that are likely to contribute to the 
neurobiological mechanisms underpinning relapse to cocaine-seeking. In addition, we 
observed distinct regulation of mGlu5R and MOPr by cue- and priming-induced 
reinstatement, highlighting the differential regulation of these receptor systems mainly in 
AcbC and BLA following the differ nt triggers of cocaine reinstatement. 
 
The behavioural data obtained from the cocaine self-administration and reinstatement 
protocol are in complete agreement with Soria et al (2008), confirming the reliability and 
validity of this operant extinction/reinstatement protocol in mice. Priming injection of 
cocaine was found to be a more potent stimulus in reinstating cocaine-seeking behaviour 
compared to the drug-associated cue, as reflected by the significantly higher number of active 
nose pokes during the priming reinstatement test.  
 
Autoradiographic brain analysis demonstrated a significant increase of mGlu5R binding in the 
LS together with a significant decrease in the BLA of mice subjected to cocaine self-
administration compared to saline controls. A similar down-regulation in the BLA was also 
shown by Hao et al. (2010), where they reported a down-regulation of mGlu5R in the BLA of 
rats with long access to cocaine. This down-regulation of mGlu5R in the BLA has been 
shown to be positively correlated with the transition from cocaine use to dependence (Hao et 
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al. 2010). Whether the region-specific alterations in the mGlu5R system observed in the 
current study underline the transition from the impulsive use to the compulsive use of cocaine 
is a matter of further investigation. Importantly, we demonstrated an up-regulation of mGlu5R 
binding following priming- but not cue- induced reinstatement of cocaine-seeking in the 
AcbC, suggestive of an mGlu5R-mediated mechanism in the induction of cocaine-primed 
reinstatement. Although, the functional significance of this upregulation cannot be firmly 
ascribed, the evidence that prevention of cocaine-induced reinstatement following an 
intra-AcbC injection of an mGlu5R negative allosteric modulator in rats (Schmidt et al. 
2014; Wang et al. 2013), points to the probability that priming-induced increase of 
mGlu5Rs might, at least partly, underlie the marked reinstatement of cocaine-seeking 
following a priming injection. The lack of upregulation of mGlu5R binding following 
cue-induced reinstatement of cocaine-seeking behaviour does not preclude the 
involvement of mGlu5R in this type of reinstatement, but merely that upregulation of 
mGlu5R binding is not the underlying mechanism. In fact, injection of mGlu5R negative 
allosteric modulators in the AcbC of rats decreased cue-induced reinstatement of 
cocaine-seeking (Wang et al 2013), which has been also mimicked in mice where 
mGlu5R was selectively knocked-down in dopamine D1 receptor-expressing neurons in the 
striatum (Novak et al. 2010).  
 
Furthermore, a significant decrease of MOPr binding was observed in the AcbC and CPu 
following cocaine self-administration and cue- but not priming-induced reinstatement 
compared to saline control groups, suggesting a differential regulation of MOPr following 
different triggers of cocaine reinstatement. These findings are supported by previous studies 
using non-contingent administration of cocaine (Hurd and Herkenham 1993; Sharpe et al. 
2000; Soderman and Unterwald 2009). However, other studies have also reported an increase 
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or no difference in MOPr activation, mRNA and binding following chronic cocaine exposure 
in the striatum (see Yoo et al. 2012). The reason for these discrepancies may lie with the 
differential effect of contingent vs non-contingent administration of cocaine, which has been 
shown to differ in terms of their molecular and behavioural effects (Markou et al. 1999; 
Metaxas et al. 2010). Interestingly, we have also demonstrated decreased levels of MOPr 
binding following cue- but not priming-induced reinstatement of cocaine-seeking in AcbC 
and CPu, as well as decreased levels of MOPr binding in cocaine self-administration 
compared to priming-induced reinstatement in CPu and VDB. Given the positive correlation 
between MOPr levels with relapse potential of cocaine use in former cocaine addicts 
(Gorelick et al. 2008), it is possible that the difference in MOPr levels observed in mice 
subjected to cue- and priming-induced reinstatement of cocaine-seeking may at least 
partly underlie the differences in the magnitude of reinstatement responses induced by 
the light cue and the priming injection of cocaine observed in our study. Of particular 
interest was our finding in the BLA, where decreased levels of MOPr binding were observed 
following cocaine extinction compared to cocaine self-administration. In this region, priming- 
but not cue-induced reinstatement of cocaine-seeking restored MOPr binding levels back to 
levels observed in the cocaine-self administration group prior to extinction. Although BLA 
has been implicated in the development of craving during withdrawal and in priming- as well 
as cue-induced reinstatement of cocaine-seeking (Shaham et al. 2003), this is the first study to 
suggest a role of the MOPr system underlying these addictive behaviours in this brain region. 
 
In contrast with MOPr binding which was altered following cocaine self-administration 
and/or cue/priming reinstatement, we did not observe any alterations in ΚOPr binding in any 
of the regions analysed, which is consistent Schroeder et al. (2003), who showed that the 
functional activity of ΚOPr was not altered following repeated chronic cocaine 
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administration. However, our findings do not rule out the recruitment of downstream ΚOPr 
pathways in cocaine addiction and reinstatement. Indeed, ΚOPr antagonists have been shown 
to prevent stress- and priming-induced reinstatement of cocaine-seeking (Al-Hasani et al. 
2013; Aldrich et al. 2013; Carey et al. 2007; Redila and Chavkin 2008).  
 
Moreover, in the present study we demonstrated a cocaine-induced increase of OTR binding 
in the CeA compared to saline controls, which is in line with previous findings from  Johns et 
al. (2004), who found increased OTR density in the amygdala of lactating rat dams following 
gestational treatment with cocaine. Since chronic cocaine administration has been shown to 
decrease hypothalamic OT content as well as plasma OT levels (Sarnyai et al. 1992), it is 
likely that the increased OTR binding observed in the CeA represents a compensatory 
neuroadaptation to a persistent hypo-oxytocinergic state induced by chronic cocaine self-
administration.  
 
Overall, the results of this study demonstrate significant region-specific neuroadaptations of 
the mGlu5R, MOPr and OTR systems following cocaine self-administration and/or cue- or 
priming-induced reinstatement of cocaine-seeking. More importantly, we demonstrated 
differential regulation of  mGlu5R and MOPr by priming- and cue-induced reinstatement of 
cocaine-seeking, consistent with findings from Ziolkowska et al. (2011), who observed 
differences in the levels of regional brain activation, as measured by induction of immediate 
early genes, following priming- compared to cue-induced reinstatement of cocaine-seeking 
behaviour.  Overall, the novel findings of the present study provide further insight into 
specific neurobiological mechanisms underlying relapse to drug-seeking and highlight 
specific differences in neurochemical adaptations depending on the challenge that triggers 
relapse (priming vs cue). These data support the importance of the development of novel 
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targeted pharmacotherapy for the prevention of relapse to cocaine-seeking following 
abstinence.   
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Figure legends: 
 
 Figure 1: Acquisition, extinction and reinstatement of cocaine-seeking behaviour.  A) 
Acquisition of cocaine self-administration behaviour is represented for the complete group of 
animals used in all the different experiments (n=36).  Male CD1 outbred mice were trained 
daily to nose poke in order to obtain a cocaine injection (1 mg/kg per infusion) paired with a 
cue light located above the active hole B) Cue-induced relapse. Nose-poke behaviour during 
the last day of cocaine self-administration, during the first and last day of extinction and 
during cue-induced reinstatement of cocaine-seeking. Animals (n=16) started the 
reinstatement session with a 5-s presentation of the light cue that was previously associated 
with cocaine administration. Nose pokes on the active hole resulted in the presentation of the 
light cue for an additional 5 s but no cocaine was delivered.  C) Cocaine priming induced 
relapse. Nose-poke behaviour during the last day of cocaine self-administration, during the 
first and last day of extinction and during priming-induced reinstatement of cocaine-seeking 
(n=9). Reinstatement was induced by a priming injection of cocaine (10 mg/kg).  No light cue 
was paired with the active nose hole to ensure the specificity of the results. Data are 
presented as mean ± SEM of number of nose pokes in 2 h operant sessions. #p < 0.05; 
###p < 0.001 vs Inactive hole; *p < 0.05; **p < 0.01; ***p < 0.001 (Two-way repeated 
measures ANOVA followed by Holm-Sidak test).  
 
Figure 2: Effect of cocaine self-administration, extinction and reinstatement of cocaine-
seeking on mGlu5R binding in mouse brain. Animals were trained to self-administer cocaine 
for 12 days. Following extinction of nose-poke behaviour, reinstatement was induced either 
by presentation of a cocaine-associated light cue or by a priming injections of cocaine 
(10 mg/kg). A) Representative computer-enhanced autoradiograms of [
3
H]MPEP (10nM) 
binding to mGluR5 in adjacent coronal brain sections of mice subjected to cocaine (coc) self-
administration (SA), extinction (Ext) and cue and priming (pri) induced reinstatement (RI) of 
cocaine-seeking together with their respective saline controls. Autoradiograms of sections 
were taken at the level of caudate putamen (Bregma: 0.62mm; first row) and amygdala 
(Bregma: -2.06mm; second row). Binding levels are represented using a pseudo-colour 
interpretation of black and white film images in fmol/mg of tissue equivalent. Representative 
autoradiograms for non-specific binding (NSB) are shown (far right column) B) Quantitative 
mGlu5R binding in brain regions of mice subjected to cocaine self-administration and cue- 
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and priming-induced reinstatement of cocaine-seeking together with their respective saline 
controls (n=5-6). Data are presented as mean ± SEM. Significant differences between saline 
and cocaine-treated animals. **p < 0.01; ***p < 0.001 (Two-way ANOVA). C) Quantitative 
mGlu5R binding in brain regions of mice subjected to cocaine self-administration and cue- 
and priming-induced reinstatement of cocaine seeking (n=5-6). One-way ANOVA followed 
by Holm-Sidak post-hoc test was performed in each individual brain region within the 
cocaine group (SA, Ext, RI cue and RI pri). Data are presented as mean ± SEM. *p < 0.05 vs 
Coc SA, Coc Ext, Coc RI cue. Abbreviations: AcbC, Nucleus accumbens core; AcbSh, 
Nucleus accumbens shell; BLA, Basolateral amygdala; CPu, Caudate putamen; LS, Lateral 
Septum 
 
Figure 3: Effect of cocaine self-administration, extinction and reinstatement of cocaine-
seeking on MOPr binding in mouse brain. Animals were trained to self-administer cocaine 
for 12 days. Following extinction of nose-poke behaviour, reinstatement was induced either 
by presentation of a cocaine-associated light cue or by a priming injections of cocaine 
(10 mg/kg). A) Representative computer-enhanced autoradiograms of [
3
H]DAMGO (4nM) 
binding to MOPr  in adjacent coronal brain sections of mice subjected to cocaine (coc) self-
administration (SA), extinction (Ext) and cue and priming (pri) induced reinstatement (RI) of 
cocaine seeking together with their respective saline controls. Autoradiograms of sections 
were taken at the level of caudate putamen (Bregma: 0.62mm; first row) and thalamus 
(Bregma: -2.06; second row). Binding levels are represented using a pseudo-colour 
interpretation of black and white film images in fmol/mg of tissue equivalent. Representative 
autoradiograms for non-specific binding (NSB) are shown (far right column) B) Quantitative 
MOPr binding in brain regions of mice subjected to cocaine self-administration and cue and 
priming-induced reinstatement of cocaine-seeking together with their respective saline 
controls (n=5-6). Significant differences between saline and cocaine-treated animals. 
**p < 0.01, ***p < 0.001 (Two-way ANOVA followed by Holm-Sidak test). C) Quantitative 
MOPr binding in brain regions of mice subjected to cocaine self-administration and cue and 
priming-induced reinstatement of cocaine-seeking (n=5-6). One-way ANOVA followed by 
Holm-Sidak post-hoc test was performed in each individual brain region within the cocaine 
groups (SA, Ext, RI cue and RI pri). Data are presented as mean ± SEM. *p < 0.05, 
**p < 0.01. Abbreviations: AcbC, Nucleus accumbens core; AcbSh, Nucleus accumbens 
shell; BLA, Basolateral amygdala; CPu, Caudate putamen; LS, Lateral Septum 
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Acquisition, extinction and reinstatement of cocaine-seeking behaviour.  A) Acquisition of cocaine self-
administration behaviour is represented for the complete group of animals used in all the different 
experiments (n=36).  Male CD1 outbred mice were trained daily to nose poke in order to obtain a cocaine 
injection (1 mg/kg per infusion) paired with a cue light located above the active hole B) Cue-induced 
relapse. Nose-poke behaviour during the last day of cocaine self-administration, during the first and last day 
of extinction and during cue-induced reinstatement of cocaine-seeking. Animals (n=16) started the 
reinstatement session with a 5-s presentation of the light cue that was previously associated with cocaine 
administration. Nose pokes on the active hole resulted in the presentation of the light cue for an additional 5 
s but no cocaine was delivered.  C) Cocaine priming induced relapse. Nose-poke behaviour during the last 
day of cocaine self-administration, during the first and last day of extinction and during priming-induced 
reinstatement of cocaine-seeking (n=9). Reinstatement was induced by a priming injection of cocaine (10 
mg/kg).  No light cue was paired with the active nose hole to ensure the specificity of the results. Data are 
presented as mean ± SEM of number of nose pokes in 2 h operant sessions. #p < 0.05; ###p < 0.001 vs 
Inactive hole; *p < 0.05; **p < 0.01; ***p < 0.001 (Two-way repeated measures ANOVA followed by Holm-
Sidak test).  
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Effect of cocaine self-administration, extinction and reinstatement of cocaine-seeking on mGlu5R binding in 
mouse brain. Animals were trained to self-administer cocaine for 12 days. Following extinction of nose-poke 
behaviour, reinstatement was induced either by presentation of a cocaine-associated light cue or by a 
priming injections of cocaine (10 mg/kg). A) Representative computer-enhanced autoradiograms of 
[3H]MPEP (10nM) binding to mGluR5 in adjacent coronal brain sections of mice subjected to cocaine (coc) 
self-administration (SA), extinction (Ext) and cue and priming (pri) induced reinstatement (RI) of cocaine-
seeking together with their respective saline controls. Autoradiograms of sections were taken at the level of 
caudate putamen (Bregma: 0.62mm; first row) and amygdala (Bregma: -2.06mm; second row). Binding 
levels are represented using a pseudo-colour interpretation of black and white film images in fmol/mg of 
tissue equivalent. Representative autoradiograms for non-specific binding (NSB) are shown (far right 
column) B) Quantitative mGlu5R binding in brain regions of mice subjected to cocaine self-administration 
and cue- and priming-induced reinstatement of cocaine-seeking together with their respective saline 
controls (n=5-6). Data are presented as mean ± SEM. Significant differences between saline and cocaine-
treated animals. **p < 0.01; ***p < 0.001 (Two-way ANOVA). C) Quantitative mGlu5R binding in brain 
regions of mice subjected to cocaine self-administration and cue- and priming-induced reinstatement of 
cocaine seeking (n=5-6). One-way ANOVA followed by Holm-Sidak post-hoc test was performed in each 
individual brain region within the cocaine group (SA, Ext, RI cue and RI pri). Data are presented as mean ± 
SEM. *p < 0.05 vs Coc SA, Coc Ext, Coc RI cue. Abbreviations: AcbC, Nucleus accumbens core; AcbSh, 
Nucleus accumbens shell; BLA, Basolateral amygdala; CPu, Caudate putamen; LS, Lateral Septum  
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Effect of cocaine self-administration, extinction and reinstatement of cocaine-seeking on MOPr binding in 
mouse brain. Animals were trained to self-administer cocaine for 12 days. Following extinction of nose-poke 
behaviour, reinstatement was induced either by presentation of a cocaine-associated light cue or by a 
priming injections of cocaine (10 mg/kg). A) Representative computer-enhanced autoradiograms of 
[3H]DAMGO (4nM) binding to MOPr  in adjacent coronal brain sections of mice subjected to cocaine (coc) 
self-administration (SA), extinction (Ext) and cue and priming (pri) induced reinstatement (RI) of cocaine 
seeking together with their respective saline controls. Autoradiograms of sections were taken at the level of 
caudate putamen (Bregma: 0.62mm; first row) and thalamus (Bregma: -2.06; second row). Binding levels 
are represented using a pseudo-colour interpretation of black and white film images in fmol/mg of tissue 
equivalent. Representative autoradiograms for non-specific binding (NSB) are shown (far right column) B) 
Quantitative MOPr binding in brain regions of mice subjected to cocaine self-administration and cue and 
priming-induced reinstatement of cocaine-seeking together with their respective saline controls (n=5-6). 
Significant differences between saline and cocaine-treated animals. **p < 0.01, ***p < 0.001 (Two-way 
ANOVA followed by Holm-Sidak test). C) Quantitative MOPr binding in brain regions of mice subjected to 
cocaine self-administration and cue and priming-induced reinstatement of cocaine-seeking (n=5-6). One-
way ANOVA followed by Holm-Sidak post-hoc test was performed in each individual brain region within the 
cocaine groups (SA, Ext, RI cue and RI pri). Data are presented as mean ± SEM. *p < 0.05, **p < 0.01. 
Abbreviations: AcbC, Nucleus accumbens core; AcbSh, Nucleus accumbens shell; BLA, Basolateral 
amygdala; CPu, Caudate putamen; LS, Lateral Septum  
254x190mm (96 x 96 DPI)  
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  Number of animals % of animals 
Animals trained to self-administer 
cocaine 
121 100 
Animals acquired cocaine self-
administration 
51 42 
Animals undergoing extinction 
training 
42 100 
Animals reaching extinction criteria 35 83 
Animals extinct after 7 days 3 9 
Animals extinct after 11 days 1 3 
Animals extinct after 12 days 26 79 
Animals extinct after 14 days 2 6 
Animals extinct after 16 days 1 3 
Animals failed to reinstate 2 8 
Table S1: Summary of the animals used in the current study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Treatment effect   Experimental phase    Interaction effect 
            Overall effects for Figure 1     
   
  
Cocaine effects on nose pokes  Factor 'hole'   Factor 'time (days)' Factor 'hole' x 'time' 
 
Self-administration (n=36) 
 
F[1,58] = 97.649;  p<0.001 
 
F[11,638] = 7.473  p<0.001 
 
F[11,638] = 14.213  p<0.001 
            Reinstatement of cocaine-seeking Factor 'hole' Factor 'experimental phase' Factor 'hole' x 'experimental phase' 
 
Cue-induced reinstatement (n=16) F[1,22] = 29.766;  p<0.001 
 
F[3,66] = 8.009;  p<0.001 
 
F[3,66] = 10.830;  p<0.001 
Priming-induced reinstatement (n=9) F[1,12] = 65.417;  p<0.001 
 
F[3,36] =45.630;  p<0.001 
 
F[3,36] = 33.762;  p<0.001 
            Overall effects for Figure 2 and Supplementary table 1        
mGluR5 autoradiography (n=5-6) Factor 'treatment'  Factor 'experimental phase' Factor 'treatment' x 'experimental phase' 
 
MtCx 
  
F[1,30] = 2.483;  p=0.126 
 
F[2,30] = 0.125;  p=0.883 
 
F[2,30] = 0.526; p=0.596 
 
PrL 
  
F[1,30] = 2.203;  p=0.140 
 
F[2,30] = 0.173;  p=0.842 
 
F[2,30] = 2.493;  p=0.100 
 
CgCx 
  
F[1,30] = 0.0103;  p=0.920 
 
F[2,30] = 0.223;  p=0.802 
 
F[2,30] = 0.514;  p=0.603 
 
CPu 
  
F[1,30] = 2.0.75;  p=0.160 
 
F[2,30] = 1.382;  p=0.267 
 
F[2,30] = 1.410;  p=0.260 
 
AcbC 
  
F[1,30] = 3.420;  p=0.074 
 
F[2,30] = 8.539;  p<0.01 
 
F[2,30] = 2.877;  p=0.0.72 
 
AcbSh 
  
F[1,30] = 0.923;  p=0.344 
 
F[2,30] = 1.691;  p=0.201 
 
F[2,30] = 0.403;  p=0.672 
 
MS 
  
F[1,29] = 0.0246;  p=0.877 
 
F[2,29] = 0.822;  p=0.450 
 
F[2,29] = 2.723;  p=0.082 
 
VDB 
  
F[1,30] = 0.494  p=0.488 
 
F[2,30] = 0.456;  p=0.638 
 
F[2,30] = 3.016;  p=0.064 
 
LS 
  
F[1,30] = 12.915;  p<0.01 
 
F[2,30] = 0.775;  p=0.470 
 
F[2,30] = 0.489;  p=0.618 
 
Hip 
  
F[1,29] = 0.784;  p=0.383 
 
F[2,29] = 0.494;  p=0.615 
 
F[2,29] = 1.132;  p=0.336 
 
Th 
  
F[1,29] = 4.134;  p=0.051 
 
F[2,29] = 0.180;  p=0.836 
 
F[2,29] = 0.0001;  p=1.000 
 
Hyp 
  
F[1,29] = 3.241;  p=0.082 
 
F[2,29] = 0.290;  p=0.750 
 
F[2,29] = 0.747;  p=0.483 
 
BLA 
  
F[1,29] = 16.375;  p<0.001 
 
F[2,28] = 0.472;  p=0.629 
 
F[2,28] = 2.837;  p=0.076 
            
       
Factor 'experimental phase' 
  
 
MtCx 
     
F[3,20] = 1.380;  p=0.278 
   
 
PrL 
     
F[3,20] = 1.203;  p=0.334 
   
 
CgCx 
     
F[3,20] = 0.489;  p=0.694 
   
 
CPu 
     
F[3,20] = 1.894;  p=0.163 
   
 
AcbC 
     
F[3,20] = 5.911;  p<0.01 
   
 
AcbSh 
     
F[3,20] = 1.184;  p=0.341 
   
 
MS 
     
F[3,20] = 1.875;  p=0.166 
   
 
VDB 
     
F[3,20] = 0.956;  p=0.433 
   
 
LS 
     
F[3,20] = 0.830;  p=0.493 
   
 
Hip 
     
F[3,19] = 1.265;  p=0.315 
   
 
Th 
     
F[3,19] = 1.202;  p=0.336 
   
 
Hyp 
     
F[3,19] = 0.567;  p=0.643 
   
 
BLA 
     
F[3,18] = 2.934;  p=0.061 
   
            Overall effects for Figure 3 and Supplementary table 2   
MOPr autoradiography(n=5-6)  Factor 'treatment'  Factor 'experimental phase' Factor 'treatment' x 'experimental phase' 
 
MtCx 
  
F[1,28] =0.247;  p=0.623 
 
F[2,28] = 1.473;  p=0.246 
 
F[2,28] = 0.313; p=0.734 
 
CgCx 
  
F[1,28] = 0.334;  p=0.568 
 
F[2,28] = 0.744;  p=0.484 
 
F[2,28] = 2.428;  p=0.107 
 
CPu 
  
F[1,30] = 28.601;  p<0.001 
 
F[2,30] = 0.882;  p=0.424 
 
F[2,30] = 3.479;  p<0.05 
 
AcbC 
  
F[1,30] = 45.492;  p<0.001 
 
F[2,30] = 6.687;  p<0.01 
 
F[2,30] = 3.893;  p<0.05 
 
AcbSh 
  
F[1,30] = 12.199;  p<0.01 
 
F[2,30] = 4.225;  p<0.05 
 
F[2,30] = 0.377;  p=0.689 
 
MS 
  
F[1,28] = 1.637;  p=0.211 
 
F[2,28] = 1.181;  p=0.322 
 
F[2,28] = 0.869;  p=0.431 
 
VDB 
  
F[1,28] = 2.345;  p=0.137 
 
F[2,28] = 1.784;  p=0.187 
 
F[2,28] = 2.582;  p=0.093 
 
LS 
  
F[1,28] = 0.0098 p=0.922 
 
F[2,28] = 0.076;  p=0.927 
 
F[2,28] = 1.633;  p=0.213 
 
VP 
  
F[1,27] = 1.171;  p=0.289 
 
F[2,27] = 0.249;  p=0.781 
 
F[2,27] = 0.594;  p=0.559 
 
Hip 
  
F[1,28] = 0.176;  p=0.678 
 
F[2,28] = 1.437;  p=0.255 
 
F[2,28] = 1.574;  p=0.225 
 
Th 
  
F[1,28] = 0.154;  p=0.698 
 
F[2,28] = 4.499;  p<0.05 
 
F[2,28] = 1.999;  p=0.154 
 
Hyp 
  
F[1,28] = 0.0796;  p=0.780 
 
F[2,28] = 1.469  p=0.247 
 
F[2,28] = 3.055;  p=0.063 
 
BLA 
  
F[1,27] = 0.344;  p=0.562 
 
F[2,27] = 3.997;  p<0.05 
 
F[2,27] = 0.820;  p=0.451 
            MOPr autoradiography (n=5-6) 
  
Factor 'experimental phase' 
 
MtCx 
     
F[3,20] =0.837;  p=0.489 
   
 CgCx 
     
F[3,20] = 1.638;  p=0.212 
   
 
CPu 
     
F[3,20] = 5.743;  p<0.01 
   
 
AcbC 
     
F[3,20] = 4.239;  p<0.05 
   
 
AcbSh 
     
F[3,20] = 2.005;  p=0.146 
   
 
MS 
     
F[3,20] = 1.118;  p=0.342 
   
 
VDB 
     
F[3,20] = 3.288;  p<0.05 
   
 
LS 
     
F[3,20] = 0.623 p=0.608 
   
 
VP 
     
F[3,20] = 0.033 p=0.992 
   
 
Hip 
     
F[3,18] = 0.764 p=0.529 
   
 
Th 
     
F[3,19] =2.825 p=0.066 
   
 
Hyp 
     
F[3,19] = 1.914 p=0.162 
   
 
BLA 
     
F[3,18] = 4.875 p<0.05 
   
 
 
          Overall effects for Table 2 
KOPr autoradiography(n=5-6)  Factor 'treatment'  Factor 'experimental phase' Factor 'treatment' x 'experimental phase' 
 AcbC 
  
F[1,30] = 0.230;  p=0.635  F[2,30] = 1.367;  p=0.270  F[2,30] = 0.0243;  p=0.976 
 AcbSh 
  
F[1,30] = 1.603;  p=0.215  F[2,30] = 0.627;  p=0.541  F[2,30] = 0.155;  p=0.857 
 CPu 
  
F[1,30] = 1.310;  p=0.261  F[2,30] = 0.778  p=0.468  F[2,30] = 1.952  p=0.160 
 Dend 
  
F[1,30] =0.104;  p=0.749  F[2,30] = 0.026;  p=0.974  F[2,30] = 0.980; p=0.387 
 MS 
  
F[1,30] = 0.418;  p=0.523  F[2,30] = 0.786;  p=0.465  F[2,30] = 1.460;  p=0.248 
 LS 
  
F[1,30] = 2.998;  p=0.094  F[2,30] =0.327;  p=0.723  F[2,30] = 1.170;  p=0.324 
 VDB 
  
F[1,30] = 2.810;  p=0.104  F[2,30] = 0.471;  p=0.629  F[2,30] = 0.765;  p=0.474 
 VP 
  
F[1,30] = 0.058 p=0.811  F[2,30] = 0.486;  p=0.620  F[2,30] = 0.958;  p=0.395 
 BNST 
  
F[1,27] = 1.374;  p=0.251  F[2,27] = 2.934;  p=0.070  F[2,27] = 0.618;  p=0.546 
 POA 
  
F[1,30] = 0.057;  p=0.813  F[2,30] = 1.829;  p=0.178  F[2,30] = 0.625;  p=0.542 
 BLA 
  
F[1,30] = 2.092;  p=0.158  F[2,30] = 7.012  p<0.01  F[2,30] =0.065;  p=0.937 
 Th 
  
F[1,30] = 0.054;  p=0.818  F[2,30] = 1.157;  p=0.328  F[2,30] = 1.342;  p=0.277 
 Hyp 
  
F[1,30] = 0.578;  p=0.453  F[2,30] = 2.962;  p=0.067  F[2,30] = 0.108;  p=0.898 
 Hip 
  
F[1,30] = 1.359;  p=0.253  F[2,30] = 1.554;  p=0.228  F[2,30] = 0.985;  p=0.385 
          
KOPr autoradiography(n=5-6) 
    
Factor 'experimental phase' 
  
 
AcbC 
     
F[3,20] = 0.681 p=0.574 
   
 
AcbSh 
     
F[3,20] = 0.128 p=0.942 
   
 
CPu 
     
F[3,20] = 0.687 p=0.571 
   
 
Dend 
     
F[3,20] = 1.013  p=0.408 
   
 
MS 
     
F[3,20] = 0.381 p=0.768 
   
 
LS 
     
F[3,20] = 0.492 p=0.692 
   
 
VDB 
     
F[3,20] = 0.030 p=0.993 
   
 
VP 
     
F[3,18] = 0.165 p=0.918 
   
 
BNST 
     
F[3,17] = 2.498  p=0.095 
   
 
POA 
     
F[3,18] = 2.124 p=0.133 
   
 
BLA 
     
F[3,20] = 3.224;  p<0.05 
   
 
Th 
     
F[3,20] = 1.183;  p=0.341 
   
 
Hyp 
     
F[3,20] = 1.162;  p=0.349 
   
 
Hip 
     
F[3,20] = 1.180;  p=0.342 
   
      
  
   OTR autoradiography(n=5-6) Factor 'treatment' Factor 'experimental phase' Factor 'treatment' x 'experimental phase' 
 
AOM 
  
F[1,28] = 4.001;  p=0.055 
 
F[2,28] = 2.580;  p=0.094 
 
F[2,28] = 0.234; p=0.793 
 
AOV 
  
F[1,30] = 0.0199;  p=0.889 
 
F[2,30] = 1.147;  p=0.331 
 
F[2,30] = 0.323;  p=0.727 
 
AOL 
  
F[1,29] = 0.477;  p=0.495 
 
F[2,29] = 0.180;  p=0.836 
 
F[2,29] = 0.278;  p=0.759 
 
CgCx 
  
F[1,29] = 0.070;  p=0.793 
 
F[2,29] = 0.141;  p=0.869 
 
F[2,29] = 1.288;  p=0.291 
 
Pir 
  
F[1,30] = 0.015;  p=0.904 
 
F[2,30] = 0.239;  p=0.789 
 
F[2,30] = 0.062;  p=0.940 
 
Acb 
  
F[1,30] = 0.385;  p=0.540 
 
F[2,30] = 1.206;  p=0.313 
 
F[2,30] = 0.840;  p=0.442 
 
CPu 
  
F[1,35] = 0.0260;  p=0.873 
 
F[2,35] = 1.853;  p=0.174 
 
F[2,35] = 1.283;  p=0.292 
 
MS 
  
F[1,30] = 1.396;  p=0.247 
 
F[2,30] = 0.756;  p=0.478 
 
F[2,30] = 0.548;  p=0.584 
 
VDB 
  
F[1,30] = 0.138;  p=0.713 
 
F[2,30] = 0.118;  p=0.889 
 
F[2,30] = 0.573;  p=0.570 
  
 
  
 
 
 
 
 
 
 
 
LS 
  
F[1,29] = 1.307;  p=0.262 
 
F[2,29] = 0.249;  p=0.782 
 
F[2,29] = 0.253;  p=0.778 
 
Hip 
  
F[1,29] = 1.648;  p=0.209 
 
F[2,29] = 2.544;  p=0.096 
 
F[2,29] = 0.897;  p=0.416 
 
Th 
  
F[1,30] = 0.0024;  p=0.961 
 
F[2,30] = 0.880;  p=0.425 
 
F[2,30] = 2.607;  p=0.090 
 
CeA 
  
F[1,30] = 7.007;  p<0.05 
 
F[2,30] = 0.641;  p=0.534 
 
F[2,30] = 0.553;  p=0.581 
 
 
          OTR autoradiography(n=6) 
    
Factor 'experimental phase' 
  
 
AOM 
     
F[3,20] = 1.471;  p=0.253 
   
 
AOV 
     
F[3,20] = 0.722;  p=0.551 
   
 
AOL 
     
F[3,20] = 0.199;  p=0.896 
   
 
CgCx 
     
F[3,18] = 1.111;  p=0.371 
   
 
Pir 
     
F[3,20] = 0.220;  p=0.881 
   
 
Acb 
     
F[3,20] = 0.991;  p=0.417 
   
 
CPu 
     
F[3,20] = 1.154;  p=0.352 
   
 
MS 
     
F[3,20] = 0.523;  p=0.672 
   
 
VDB 
     
F[3,23] = 0.342;  p=0.795 
   
 
LS 
     
F[3,20] = 0.541;  p=0.660 
   
 
Hip 
     
F[3,20] = 1.285;  p=0.307 
   
 
Th 
     
F[3,20] = 1.172;  p=0.914 
   
 
CeA 
     
F[3,20] = 1.154;  p=0.352 
                           
 
Table S2: Relevant effects for Biochemical and Behavioural Data 
    
  
 
Motor Cortex 136.0 ± 10.6 124.1 ± 8.6 139.1 ± 12.3 125.6 ± 14.5 138.7 ± 6.8 148.3 ± 8.1 121.5 ± 10.8
Prelimbic Cortex 158.4 ± 11.8 124.3 ± 7.1 152.1 ± 17.8 149.3 ± 16.5 154.6 ± 10.5 174.1 ± 11.7 143.6 ± 8.0
Cingulate Cortex 151.1 ± 8.2 139.6 ± 7.8 151.2 ± 6.9 163.1 ± 16.4 149.7 ± 17.9 156.4 ± 21.5 135.2 ± 10.6
Medial septum 144.0 ± 13.2 116.4 ± 5.1 144.4 ± 13.4 140.7 ± 12.3 110.2 ± 16.7 141.5 ± 13.9 109.1 ± 9.0
Thalamus 98.2 ± 10.3 92.8 ± 6.8 81.0 ± 11.2 96.1 ± 10.2 83.4 ± 8.6 78.0 ± 4.4 82.1 ± 4.5
Hypothalamus 106.8 ± 16.3 101.7 ± 3.9 81.9 ± 5.5 111.1 ± 12.3 100.4 ± 9.7 92.5 ± 7.5 101.8 ± 10.9
Hippocambus 139.5 ± 12.1 136.6 ± 8.0 133.6 ± 14.1 158.6 ± 10.2 143.4 ± 9.9 135.5 ± 4.1 146.5 ± 9.5
 Table S3: : Values represent the mean ± SEM of 5-6 animals per group
Cocaine Ext
 Effect of acquisition of cocaine self-administration, extinction, cue- and priming-induced reinstatement of cocaine-seeking on mGlu5R binding in mouse brain
[
3
H]-MPEP specific binding 
(fmol/mg tissue equivalent)
Cocaine cue RI Cocaine pri RICocaine SA
Brain Region
 Saline SA  Saline cue RI  Saline pri RI
Motor Cortex 32.4 ± 3.7 26.9 ± 3.4 29.6 ± 3.1 29.7 ± 3.9 22.2 ± 1.8 30.1 ± 4.3 26.7 ± 5.0
Cingulate Cortex 38.9 ± 3.3 32.5 ± 2.9 35.9 ± 2.9 28.2 ± 3.5 33.0 ± 4.0 36.9 ± 3.3 28.7 ± 4.4
Medial septum 58.7 ± 3.0 50.8 ± 7.7 56.1 ± 3.9 40.4 ± 8.2 44.1 ± 4.8 52.7 ± 5.4 39.5 ± 4.2
Ventral pallidum 58.0 ± 3.5 53.1 ± 1.5 59.6 ± 2.5 49.9 ± 7.7 51.2 ± 7.2 50.0 ± 5.0 49.9 ± 4.4
Thalamus 49.7 ± 4.0 36.7 ± 2.1 43.4 ± 2.5 40.1 ± 3.2 36.9 ± 4.7 48.2 ± 2.6 33.0 ± 4.6
Hypothalamus 66.9 ± 4.5 58.0 ± 4.8 59.6 ± 4.9 53.8 ± 7.0 59.9 ± 4.3 67.4 ± 3.1 50.8 ± 5.1
Hippocampus 24.9 ± 2.0 20.5 ± 3.8 21.7 ± 1.5 19.0 ± 2.6 18.3 ± 3.1 25.3 ± 2.3 16.4 ± 6.1
Table S4: Values represent the mean ± SEM of 5-6 animals per group 
Cocaine Ext
 Effect of acquisition of cocaine self-administration, cue- and priming-induced reinstatement of cocaine-seeking on μ receptor binding in mouse brain
[
3
H]-DAMGO specific binding 
(fmol/mg tissue equivalent)
Cocaine cue RI Cocaine pri RICocaine SA
Brain Region
 Saline SA  Saline cue RI  Saline pri RI
